trending Market Intelligence /marketintelligence/en/news-insights/trending/gxzsqhsr2z8mdwsyp226sw2 content esgSubNav
In This List

Charles River Laboratories secures $95.7M contract from US agency

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Charles River Laboratories secures $95.7M contract from US agency

Charles River Laboratories International Inc. said it received a $95.7 million contract from a U.S. agency to manage its vivarium, an area for keeping and raising animals for observation or research.

The contract from the U.S. National Institute of Allergy and Infectious Diseases, or NIAID, will see the Wilmington, Mass.-based company provide 200 employees who will be responsible for technical and support services required for biomedical research.

The contract will initially run through Sept. 13, 2019, but includes annual renewal options for an additional four years through Sept. 13, 2023.

According to Charles River, which provides research services to healthcare companies and government agencies, the contract will generate $18 million in revenues over the initial 12-month period, with modest increases in each of the subsequent periods.